MKI67 and neuroendocrine neoplasm: We were unable to access individual clinical, histological, and Ki-67 immunoexpression data, which in turn hindered the classification of Neuroendocrine Tumors (NETs) based on differentiation degree, thereby limiting a more in-depth analysis of the clinical behavior of various NET types.